AZIYO BIOLOGICS, INC.·4

May 11, 4:40 PM ET

LLOYD RONALD K. 4

4 · AZIYO BIOLOGICS, INC. · Filed May 11, 2021

Insider Transaction Report

Form 4
Period: 2021-05-07
LLOYD RONALD K.
DirectorPresident and CEO
Transactions
  • Purchase

    Class A Common Stock

    2021-05-07$12.28/sh+1,367$16,78723,151 total
  • Purchase

    Class A Common Stock

    2021-05-07$11.65/sh+7,198$83,85721,784 total
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.20 to $12.18. The reporting person undertakes to provide Aziyo Biologics, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.25 to $12.39. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Documents

1 file
  • 4
    tm2115948-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT